BioAge Labs Inc’s filing revealed that its Principal Accounting Officer Barton Shane acquired Company’s shares for reported $47376.0 on Sep 27 ’24. In the deal valued at $18.00 per share,2,632 shares were bought. As a result of this transaction, Barton Shane now holds 2,632 shares worth roughly $11264.960000000001.
Then, Pande Vijay Satyanand bought 126,793 shares, generating $2,501,626 in total proceeds. Upon buying the shares at $19.73, the Director now owns 1,026,793 shares.
Before that, Pande Vijay Satyanand bought 67,096 shares. BioAge Labs Inc shares valued at $1,323,804 were divested by the Director at a price of $19.73 per share. As a result of the transaction, Pande Vijay Satyanand now holds 1,093,889 shares, worth roughly $4.68 million.
William Blair initiated its BioAge Labs Inc [BIOA] rating to a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in early December from “an Overweight” to “an Underweight”. Jefferies also remained covering BIOA and has decreased its forecast on December 09, 2024 with a “Hold” recommendation from previously “Buy” rating. Citigroup revised its rating on December 09, 2024. It rated BIOA as “a Neutral” which previously was an “a Buy”.
Price Performance Review of BIOA
On Tuesday, BioAge Labs Inc [NASDAQ:BIOA] saw its stock fall -5.73% to $4.28. Over the last five days, the stock has gained 0.71%. BioAge Labs Inc shares have fallen nearly -26.08% since the year began.
Levels Of Support And Resistance For BIOA Stock
The 24-hour chart illustrates a support level at 4.13, which if violated will result in even more drops to 3.97. On the upside, there is a resistance level at 4.47. A further resistance level may holdings at 4.66. The Relative Strength Index (RSI) on the 14-day chart is 43.45, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 69.23%. Stochastics %K at 60.90% indicates the stock is a holding.
How much short interest is there in BioAge Labs Inc?
A steep rise in short interest was recorded in BioAge Labs Inc stocks on 2025-03-14, dropping by -0.24 million shares to a total of 1.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 1.99 million shares. There was a decline of -13.75%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 21, 2024 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating along with a $40 price target.
